ImmunologybioRxiv
Prophylactic intranasal administration of a TLR2 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model
DOI 10.1016/j.ebiom.2020.103153
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
3 papers
Recent·Most cited
K. M. Mangas, N. J. Tobias, E. Marion…·T. P. Stinear
This study evaluates the vaccine potential of M. ulcerans antigens Hsp18 and MUL_3720 in mice, finding high antibody titres but no significant protection against Buruli ulcer.
K. M. Mangas, A. H. Buultjens, J. L. Porter…·T. P. Stinear
This study evaluates a prime-boost vaccine against Mycobacterium ulcerans in mice, finding that both the experimental ER vaccine and BCG provide significant protection through distinct immune profiles.